Xu XF - Search Results

1

PARP1 acetylation at K119 is essential in regulating the progression and proliferation of cervical cancer cells.

Yang LL, Zhang XK, Cao Y, Shi LY, Xie SY, Yang YJ, Wu SJ, Sun HZ, Tang XJ, Yuan DL, Zhang D, Xu XF, Li Q, Ying XY. Yang LL, et al. Among authors: xu xf. Med Oncol. 2024 Oct 14;41(11):273. doi: 10.1007/s12032-024-02315-7. Med Oncol. 2024. PMID: 39400626

2

Artemin Promotes the Migration and Invasion of Cervical Cancer Cells through AKT/mTORC1 Signaling.

Zhu M, Zhou L, Fu J, Wang Y, Xu X, Wu J, Kong X, Li J, Zhou Z, Zhou H. Zhu M, et al. J Oncol. 2022 Nov 26;2022:3332485. doi: 10.1155/2022/3332485. eCollection 2022. J Oncol. 2022. PMID: 36471885 Free PMC article.

3

microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.

Zhou H, Xu X, Xun Q, Yu D, Ling J, Guo F, Yan Y, Shi J, Hu Y. Zhou H, et al. Oncol Rep. 2012 Mar;27(3):807-12. doi: 10.3892/or.2011.1574. Epub 2011 Dec 1. Oncol Rep. 2012. PMID: 22139444

4

microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3.

Yu D, Zhou H, Xun Q, Xu X, Ling J, Hu Y. Yu D, et al. Oncol Lett. 2012 Jun;3(6):1221-1226. doi: 10.3892/ol.2012.638. Epub 2012 Mar 8. Oncol Lett. 2012. PMID: 22783422 Free PMC article.

5

Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.

Xu X, Kong X, Liu T, Zhou L, Wu J, Fu J, Wang Y, Zhu M, Yao S, Ding Y, Ding L, Li R, Zhu X, Tang X, Zhang Y, Yang Q, Ling J, Zhou H. Xu X, et al. Gynecol Oncol. 2019 Jul;154(1):207-217. doi: 10.1016/j.ygyno.2019.04.005. Epub 2019 Apr 9. Gynecol Oncol. 2019. PMID: 30979588

6

Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.

Xu X, Liu T, Wu J, Wang Y, Hong Y, Zhou H. Xu X, et al. Cancer Gene Ther. 2019 Nov;26(11-12):356-365. doi: 10.1038/s41417-019-0078-x. Epub 2019 Jan 17. Cancer Gene Ther. 2019. PMID: 30651591

7

Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer.

Wu J, Cheng Z, Xu X, Fu J, Wang K, Liu T, Wu C, Kong X, Yang Q, Yan G, Zhou H. Wu J, et al. Front Oncol. 2019 May 22;9:422. doi: 10.3389/fonc.2019.00422. eCollection 2019. Front Oncol. 2019. PMID: 31192127 Free PMC article.

8

Prognostic nomograms for locally advanced cervical cancer based on the SEER database: Integrating Cox regression and competing risk analysis.

Zhang Y, Meng YP, Xu XF, Shi Q. Zhang Y, et al. Among authors: xu xf. Medicine (Baltimore). 2024 Nov 8;103(45):e40408. doi: 10.1097/MD.0000000000040408. Medicine (Baltimore). 2024. PMID: 39533612 Free PMC article.

9

Uterine smooth muscle tumors of uncertain malignant potential: a 13-year retrospective study.

Liu L, Xiao Z, Li Z, Zheng J, Xu X, Zhou H. Liu L, et al. Front Oncol. 2024 Nov 7;14:1458968. doi: 10.3389/fonc.2024.1458968. eCollection 2024. Front Oncol. 2024. PMID: 39575428 Free PMC article.

10

Dual‑regulated oncolytic adenovirus carrying ERCC1‑siRNA gene possesses potent antitumor effect on ovarian cancer cells.

Zhao T, Ye W, Zhang R, Zhu X, Shi Q, Xu X, Chen W, Xu L, Meng Y. Zhao T, et al. Mol Med Rep. 2024 Jul;30(1):120. doi: 10.3892/mmr.2024.13245. Epub 2024 May 17. Mol Med Rep. 2024. PMID: 38757346 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

638 results

Search Page

Filters